◀ Back to ALB

ALB — CRP

Text-mined interactions from Literome

Iseki et al., Nephrol Dial Transplant 1999 : CRP is a significant predictor of death in chronic dialysis patients, independent of serum albumin and other possible confounders
Kalender et al., Int J Clin Pract 2002 (Anemia) : In the present study, the effects of C-reactive protein (CRP) and ferritin on serum albumin , transferrin and haemoglobin ( Hb ) were assessed to investigate the relationship between inflammation, hypoalbuminaemia and anaemia in haemodialysis patients
Jones et al., J Ren Nutr 2002 (Body Weight...) : In multivariate analysis, predialysis albumin was dependent on nPCR ( P =.04 ), CRP ( P < .0001 ), and predialysis Vecf % Vtbw ( P =.002 ), and postdialysis albumin was dependent on nPCR ( P =.01 ), CRP ( P =.002 ), and postdialysis Vecf % Vtbw ( both P < .0001 )
Vernaglione et al., Am J Kidney Dis 2004 (Cardiovascular Diseases) : Administration of atorvastatin is safe in patients on long-term HD therapy and, in addition to its beneficial effects on lipid levels, induces a significant decrease in serum CRP levels, with a consequential increase in serum albumin levels
Chazot et al., Kidney Int 2013 : The Monitoring Dialysis Outcomes ( MONDO ) database shows that in 40,000 dialysis patients worldwide who died, systolic blood pressure, interdialytic weight gain, and serum albumin declined progressively, and C-reactive protein increased more than 12 months before death, indicating that predictive models may be developed to enable nephrologists to improve the clinical outcome of dialysis patients